Oramed Pharmaceuticals Inc. SEC filings ORMP
Oramed Pharmaceuticals Inc. has 941 filings in SEC EDGAR's recent list, going back to Nov 29, 2002. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 19, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 10-QT | Transition report | Mar 30, 2022 | Dec 31, 2021 |
| 10-Q | Quarterly report | Jan 11, 2022 | Nov 30, 2021 |
| 10-Q | Quarterly report | Jul 14, 2021 | May 31, 2021 |
| 10-Q | Quarterly report | Apr 13, 2021 | Feb 28, 2021 |
| 10-Q | Quarterly report | Jan 14, 2021 | Nov 30, 2020 |
| 10-Q | Quarterly report | Jul 7, 2020 | May 31, 2020 |
| 10-Q | Quarterly report | Apr 6, 2020 | Feb 29, 2020 |
| 10-Q | Quarterly report | Jan 9, 2020 | Nov 30, 2019 |
| 10-Q | Quarterly report | Jul 10, 2019 | May 31, 2019 |
| 10-Q | Quarterly report | Apr 10, 2019 | Feb 28, 2019 |
| 10-Q | Quarterly report | Jan 14, 2019 | Nov 30, 2018 |
| 10-Q | Quarterly report | Jul 12, 2018 | May 31, 2018 |
| 10-Q | Quarterly report | Apr 9, 2018 | Feb 28, 2018 |
| 10-Q | Quarterly report | Jan 11, 2018 | Nov 30, 2017 |
| 10-Q | Quarterly report | Jul 6, 2017 | May 31, 2017 |
| 10-Q | Quarterly report | Apr 5, 2017 | Feb 28, 2017 |
| 10-Q | Quarterly report | Jan 11, 2017 | Nov 30, 2016 |
| 10-Q | Quarterly report | Jul 6, 2016 | May 31, 2016 |
| 10-Q | Quarterly report | Apr 6, 2016 | Feb 29, 2016 |
| 10-Q | Quarterly report | Jan 13, 2016 | Nov 30, 2015 |
| 10-Q | Quarterly report | Jul 1, 2015 | May 31, 2015 |
| 10-Q | Quarterly report | Apr 3, 2015 | Feb 28, 2015 |
| 10-Q | Quarterly report | Jan 8, 2015 | Nov 30, 2014 |
| 10-Q | Quarterly report | Jul 14, 2014 | May 31, 2014 |
| 10-Q | Quarterly report | Apr 10, 2014 | Feb 28, 2014 |
| 10-Q | Quarterly report | Jan 14, 2014 | Nov 30, 2013 |
| 10-Q | Quarterly report | Jul 17, 2013 | May 31, 2013 |
| 10-Q | Quarterly report | Apr 11, 2013 | Feb 28, 2013 |
| 10-Q/A | Amended quarterly report | Dec 27, 2012 | Nov 30, 2012 |
| 10-Q | Quarterly report | Dec 26, 2012 | Nov 30, 2012 |
| 10-Q | Quarterly report | Jul 12, 2012 | May 31, 2012 |
| 10-Q | Quarterly report | Apr 4, 2012 | Feb 29, 2012 |
| 10-Q | Quarterly report | Jan 12, 2012 | Nov 30, 2011 |
| 10-Q | Quarterly report | Jul 13, 2011 | May 31, 2011 |
| 10-Q | Quarterly report | Apr 12, 2011 | Feb 28, 2011 |
| 10-Q | Quarterly report | Jan 13, 2011 | Nov 30, 2010 |
| 10-Q | Quarterly report | Jul 14, 2010 | May 31, 2010 |
| 10-Q | Quarterly report | Apr 12, 2010 | Feb 28, 2010 |
| 10-Q | Quarterly report | Jan 13, 2010 | Nov 30, 2009 |
| 10-Q | Quarterly report | Jul 13, 2009 | May 31, 2009 |
| 10-Q | Quarterly report | Mar 30, 2009 | Feb 28, 2009 |
| 10-Q | Quarterly report | Jan 13, 2009 | Nov 30, 2008 |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORMP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1176309
- Former names
- Integrated Security Technologies, Inc. (until Apr 10, 2006); IGUANA VENTURES LTD (until Jun 10, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.